The Food and Medicines Administration (FDA in English) of the United States approved a new batch of updated anticovid vaccines but limited them to the population with health risks, and also rescinded the authorization for emergency use.
The agency authorized modern reinforcement vaccines (from 6 months of age), Pfizer (5 years) and Novavax (12 years old), but now they will be available only after medical consultation and for “high -risk patients,” said the Secretary of Health and Human Services, Robert F. Kennedy Jr., in X.
This high-risk population covers those over 65 in general, and adults and children with some health condition that can result in a “serious” disease after infection with COVID-19, according to a Pfizer statement, for example asthma, obesity, cancer or diabetes.
Kennedy Jr. disclosed the actions of the FDA – who did not issue a statement – and equated them to the “compliance” of several electoral promises, mainly ending the government imposition of vaccinating against the Coronavirus and allowing him to do it whoever wants, especially the “vulnerable.”
“Emergency use authorizations for Covid vaccines, one day used to justify broad impositions on the general public during the administration of (Joe) Biden), have now been terminated,” added the head of Health.
Kennedy Jr. also indicated that as part of the green light of the regulator, pharmaceuticals will have to make clinical trials of these vaccines with placebo.
The announcement is a turn in the Vaccination policy against the US COVID-19, as the Biden government recommended an annual reinforcement vaccine from 6 months of age, and aligns with Kennedy Jr.’s skepticism towards vaccines.
In June, Kennedy Jr. dismissed the 17 members of the committee who advised who should be vaccinated, including children, in the centers for disease control and prevention (CDC) ensuring that such action returned the public’s confidence in vaccines, which was criticized by health experts.
